Apollo Hospitals Enterprise
₹8,133.50Change from previous close: −0.39%Absolute change: −₹32.00
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ₹1.17T
- Enterprise value
- ₹1.24T
- P/E (trailing 12 months)
- 56.1
- Forward P/E
- 37.3
- Price/book
- 12.3
- Price/sales
- 4.42
- EV/EBITDA
- 33.6
- EV/revenue
- 4.70
Profitability and growth
- Gross margin
- 35.2%
- Operating margin
- 12.2%
- Net margin
- 7.9%
- Revenue growth (year over year)
- 20.6%
- Earnings growth (year over year)
- 34.1%
Financial health
- Total cash
- ₹18.56B
- Total debt
- ₹84.93B
- Debt/equity
- 0.85
Dividends
- Annual dividend per share
- ₹20.00
- Dividend yield
- 0.3%
- Payout ratio
- 13.8%
- Ex-dividend date
- August 14, 2026
Analysts and estimates
- Average price target
- ₹9,811.67
- Median price target
- ₹10,000.00
- High price target
- ₹10,800.00
- Low price target
- ₹6,230.00
- Analysts with a price target
- 30
- Consensus
- Strong buy
- Forward EPS
- ₹217.89
- EPS estimate, current year
- ₹171.82
Shares and trading
- Beta
- 0.20
- Average volume
- 368.47K
- Shares outstanding
- 143.78M
- Float
- 99.6M
- Institutional ownership
- 50.4%
- Insider ownership
- 28.4%